Cargando…

Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer

BACKGROUND AND AIM: Given their poor prognosis, patients with residual disease (RD) in the re-resection specimen of an incidental gallbladder carcinoma (IGBC) could benefit from a better selection for surgical treatment. The Gallbladder Cancer Risk Score (GBRS) has been proposed to preoperatively id...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Emilio, Lluis, Nuria, Llado, Laura, Torras, Jaume, Busquets, Juli, Rafecas, Antoni, Serrano, Teresa, Mils, Kristel, Leiva, David, Fabregat, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982379/
https://www.ncbi.nlm.nih.gov/pubmed/31980034
http://dx.doi.org/10.1186/s12957-020-1794-2
_version_ 1783491300605034496
author Ramos, Emilio
Lluis, Nuria
Llado, Laura
Torras, Jaume
Busquets, Juli
Rafecas, Antoni
Serrano, Teresa
Mils, Kristel
Leiva, David
Fabregat, Joan
author_facet Ramos, Emilio
Lluis, Nuria
Llado, Laura
Torras, Jaume
Busquets, Juli
Rafecas, Antoni
Serrano, Teresa
Mils, Kristel
Leiva, David
Fabregat, Joan
author_sort Ramos, Emilio
collection PubMed
description BACKGROUND AND AIM: Given their poor prognosis, patients with residual disease (RD) in the re-resection specimen of an incidental gallbladder carcinoma (IGBC) could benefit from a better selection for surgical treatment. The Gallbladder Cancer Risk Score (GBRS) has been proposed to preoperatively identify RD risk more precisely than T-stage alone. The aim of this study was to assess the prognostic value of RD and to validate the GBRS in a retrospective series of patients. MATERIAL AND METHODS: A prospectively collected database including 59 patients with IGBC diagnosed from December 1996 to November 2015 was retrospectively analyzed. Three locations of RD were established: local, regional, and distant. The effect of RD on overall survival (OS) was analyzed with the Kaplan-Meier method. To identify variables associated with the presence of RD, characteristics of patients with and without RD were compared using Fisher’s exact test. The relative risk of RD associated with clinical and pathologic factors was studied with a univariate logistic regression analysis. RESULTS: RD was found in 30 patients (50.8%). The presence of RD in any location was associated with worse OS (29% vs. 74.2%, p = 0.0001), even after an R0 resection (37.7% vs 74.2%, p = 0.003). There was no significant difference in survival between patients without RD and with local RD (74.2% vs 64.3%, p = 0.266), nor between patients with regional RD and distant RD (16.1% vs 20%, p = 0.411). After selecting patients in which R0 resection was achieved (n = 44), 5-year survival rate for patients without RD, local RD, and regional RD was, respectively, 74.2%, 75%, and 13.9% (p = 0.0001). The GBRS could be calculated in 25 cases (42.3%), and its usefulness to predict the presence of regional or distant RD (RDRD) was confirmed (80% in high-risk patients and 30% in intermediate risk p = 0.041). CONCLUSION: RDRD, but not local RD, represents a negative prognostic factor of OS. The GBRS was useful to preoperatively identify patients with high risk of RDRD. An R0 resection did not improve OS of patients with regional RD.
format Online
Article
Text
id pubmed-6982379
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69823792020-01-29 Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer Ramos, Emilio Lluis, Nuria Llado, Laura Torras, Jaume Busquets, Juli Rafecas, Antoni Serrano, Teresa Mils, Kristel Leiva, David Fabregat, Joan World J Surg Oncol Research BACKGROUND AND AIM: Given their poor prognosis, patients with residual disease (RD) in the re-resection specimen of an incidental gallbladder carcinoma (IGBC) could benefit from a better selection for surgical treatment. The Gallbladder Cancer Risk Score (GBRS) has been proposed to preoperatively identify RD risk more precisely than T-stage alone. The aim of this study was to assess the prognostic value of RD and to validate the GBRS in a retrospective series of patients. MATERIAL AND METHODS: A prospectively collected database including 59 patients with IGBC diagnosed from December 1996 to November 2015 was retrospectively analyzed. Three locations of RD were established: local, regional, and distant. The effect of RD on overall survival (OS) was analyzed with the Kaplan-Meier method. To identify variables associated with the presence of RD, characteristics of patients with and without RD were compared using Fisher’s exact test. The relative risk of RD associated with clinical and pathologic factors was studied with a univariate logistic regression analysis. RESULTS: RD was found in 30 patients (50.8%). The presence of RD in any location was associated with worse OS (29% vs. 74.2%, p = 0.0001), even after an R0 resection (37.7% vs 74.2%, p = 0.003). There was no significant difference in survival between patients without RD and with local RD (74.2% vs 64.3%, p = 0.266), nor between patients with regional RD and distant RD (16.1% vs 20%, p = 0.411). After selecting patients in which R0 resection was achieved (n = 44), 5-year survival rate for patients without RD, local RD, and regional RD was, respectively, 74.2%, 75%, and 13.9% (p = 0.0001). The GBRS could be calculated in 25 cases (42.3%), and its usefulness to predict the presence of regional or distant RD (RDRD) was confirmed (80% in high-risk patients and 30% in intermediate risk p = 0.041). CONCLUSION: RDRD, but not local RD, represents a negative prognostic factor of OS. The GBRS was useful to preoperatively identify patients with high risk of RDRD. An R0 resection did not improve OS of patients with regional RD. BioMed Central 2020-01-24 /pmc/articles/PMC6982379/ /pubmed/31980034 http://dx.doi.org/10.1186/s12957-020-1794-2 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ramos, Emilio
Lluis, Nuria
Llado, Laura
Torras, Jaume
Busquets, Juli
Rafecas, Antoni
Serrano, Teresa
Mils, Kristel
Leiva, David
Fabregat, Joan
Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
title Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
title_full Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
title_fullStr Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
title_full_unstemmed Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
title_short Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
title_sort prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982379/
https://www.ncbi.nlm.nih.gov/pubmed/31980034
http://dx.doi.org/10.1186/s12957-020-1794-2
work_keys_str_mv AT ramosemilio prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT lluisnuria prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT lladolaura prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT torrasjaume prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT busquetsjuli prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT rafecasantoni prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT serranoteresa prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT milskristel prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT leivadavid prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer
AT fabregatjoan prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer